Key result
In patients hospitalized with acute heart failure, the 30-day readmission rate was 6.6%, with independent predictors including history of device implantation (OR 23.82), lower LVEF, wide QRS, and higher BUN, Pro-BNP, and uric acid levels.
Why the study?
Heart failure hospitalization accounts for significant healthcare costs, and unchanging readmission rates highlight the need to identify predictors of readmission.
What are the clinical and laboratory predictors of early readmission and mortality in hospitalized patients with HFrEF?
Cohort (n=428)
No
What are the clinical and laboratory predictors of early readmission and mortality in hospitalized patients with HFrEF?
Odds Ratio: 23.82 (95% CI 2.33–242.59)
p-value: p=0.007
In hospitalized patients with HFrEF, history of device implantation, lower LVEF, wide QRS, and elevated BUN, Pro-BNP, and uric acid are independent predictors of early readmission.
No takes yet. Share an insight, caveat, or question.
Identifies potential prognostic markers for heart failure readmission but should not yet change practice.
Naderi et al. (2022) conducted a cohort in Acute heart failure with reduced ejection fraction (HFrEF) (n=428). Risk factors for early readmission (e.g., cardiac device implantation) vs. Patients without these risk factors was evaluated on Early (30-day) readmission (OR 23.82, 95% CI 2.33-242.59, p=0.007). In patients hospitalized with acute heart failure, the 30-day readmission rate was 6.6%, with independent predictors including history of device implantation (OR 23.82), lower LVEF, wide QRS, and higher BUN, Pro-BNP, and uric acid levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: